PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2011 2012
This project aims to support the HIV/AIDS national strategy through the strengthening of laboratory services for implementation of the National Antiretroviral Therapy (ART) guidelines, in line with WHO ART recommendations and improving the quality of care provided to HIV/AIDS patients. This is achieved through: 1: Increasing access to CD4 testing for HIV positive patients to support the roll out of the ART program according to the new WHO guidelines, by establishing High through-put Supra-laboratories and establishing a Structured Specimen Transport/Referral network. 2: Providing access to other laboratory tests essential to monitoring the health of people living with HIV/AIDS and the side effects of ART, that is Chemistry and Hematology tests 3: Facilitating access to specialized testing and opportunistic infection diagnosis through establishment of a referral network from district hospitals and rural clinics to provincial labs with more advanced testing capacity such as TB culture and DST and EID and 4: Increasing access to lab monitoring of patients on ART for early identification of treatment failure through Viral Load testing.a. VEHICLES Purchased under this mechanism from the start of the mechanism through COP FY2011 = 1. New requests in COP FY 2012 = 2. Total planned/purchased vehicles for the life of this mechanism = 3 b. New request justification - COP FY 2012: The vehicles will be used to monitor implementation of activities under this CoAg, ensuring that the laboratory referral system is operating efficiently and effectively and also the Supra-Labs is producing and delivering results within acceptable time frames.
Global Fund / Programmatic Engagement Questions
1. Is the Prime Partner of this mechanism also a Global Fund principal or sub-recipient, and/or does this mechanism support Global Fund grant implementation? Yes2. Is this partner also a Global Fund principal or sub-recipient? Neither3. What activities does this partner undertake to support global fund implementation or governance?
Budget Code Recipient(s) of Support Approximate Budget Brief Description of ActivitiesHLAB MOHCW 700000 Lab strenthening to provide lab monitoring services to HIV positive patients.HVSI MOHCW 200000 Strengthening of information management systems to support laboratory monitoring at public health facility laboratories.HVTB MOHCW 300000 Commodities and equipment for laboratories to provide diagnostic and monitoring services for TB infected patients.
It will support the validation, and roll out of diagnostic technologies such as the Gene Expert for Viral Load testing, HIVDR, MDR-TB PCR techniques. Specific outcomes include: Capacitate at least 8 laboratories with high capacity field performing equipment and reagents/cartridges for HIV and TB laboratory tests and monitoring.The project will provide technical and management support to the National Microbiology Reference Laboratory (NMRL) and the National TB Reference Laboratory (NTBRL) for the conduct of national surveys such as the ANC survey, the HIV-DR survey and the MDR-TB survey. This project will also provide salary support to personnel (two Laboratory Scientists) at NMRL who are responsible for testing specimens for national surveys.
This project will establish, 8 high through-put Supra Labs thus increasing access to CD4 testing for HIV positive patients to support the roll out of the ART program according to the new WHO guidelines. It will provide for other laboratory tests essential to monitoring the health of people living with HIV/AIDS and the side effects of ART, such as liver function and hematology tests. High capacity laboratory equipment, reagents and laboratory commodities will be procured for the Supra-Labs. Personnel at the Supra-Labs will receive a performance allowances for meeting set targets of tests conducted. A structured specimen referral network using motor-bikes will be established for the transportation of specimens from requesting clinic to the Supra-Labs for testing and transporting patient results from the Supra-Labs to the clinics. Based on a baseline assessment minor renovations will be carried out on the selected laboratories in order to optimize work-flow and efficiency.Personnel at the Supra-Labs will be mentored in order to build capacity for high volume testing and DNA PCR. A Laboratory Data Management System (LDMS) for data collection, and reporting will be installed at each site. The laboratory logistics unit will be strengthened by providing additional personnel and establishing a reagent and commodity procurement and distribution system for the Supra-Labs to avoid stock outs and ensure uninterrupted service delivery.The Supra-Labs will receive all the other EQA services provided by ZINQAP such as an accredited PT programme.
The Project will provide laboratory equipment, reagents / cartridges and commodities for laboratory testing in CD4 Clinical Chemistry and Full blood count. The project will test a total of 125,000 tests per year. The project will also support specialised testing such as EID and DNA PCR of specimens collected at provincial and disrtict laboratories at the National Microbiology Reference Laboratory (NMRL). It will provide for increased access to laborarory monitoring of patients on ART for early identification treatment failure. The project will provide technical and management support to the National Microbiology Reference Laboratory (NMRL) and the National TB Reference Laboratory (NTBRL) for the conduct of national surveys such as the ANC survey, the HIV-DR survey and the MDR-TB survey. This project will also provide salary support to personnel (two Laboratory Scientists) at NMRL who are responsible for testing specimens for national surveys.
